Percutaneous n-butyl cyanoacrylate embolization of cervical metastatic disease via an anterolateral approach.

Autor: Sabal LT; University of Minnesota Medical School, Minneapolis, MN, USA., Topiwala K; Department of Neurological Surgery, University of Minnesota, Minneapolis, MN, USA., Jagadeesan B; Department of Neurological Surgery, University of Minnesota, Minneapolis, MN, USA., Tummala R; Department of Neurological Surgery, University of Minnesota, Minneapolis, MN, USA.
Jazyk: angličtina
Zdroj: Radiology case reports [Radiol Case Rep] 2023 Nov 25; Vol. 19 (2), pp. 642-646. Date of Electronic Publication: 2023 Nov 25 (Print Publication: 2024).
DOI: 10.1016/j.radcr.2023.11.025
Abstrakt: Symptomatic vascular spinal metastases will benefit from pre-operative tumor embolization - percutaneous with or without adjunct endovascular embolization. However, when a transpedicular approach is not feasible, an anterolateral approach may be a viable alternative. The authors report a 57-year-old woman with prior C3-T1 instrumentation who presented with acute cord compression from a pathologic C5 vertebral body fracture related to metastatic renal cell carcinoma. The patient underwent CT-guided direct tumor embolization with 33% n-butyl-2-cyanoacrylate via an anterolateral approach, followed by C5-corpectomy and anterior cervical C4-C6 fusion and plating with minimal blood loss (est. 20 cc) and a stable neurological exam post-operatively. In patients with highly vascular cervical metastatic disease who lack a viable transpedicular approach for preoperative tumor embolization, a CT-guided anterolateral approach is a viable alternative.
(© 2023 The Authors. Published by Elsevier Inc. on behalf of University of Washington.)
Databáze: MEDLINE